SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Biolase, Inc – ‘10-Q’ for 9/30/13 – ‘R2’

On:  Tuesday, 11/12/13, at 8:52am ET   ·   For:  9/30/13   ·   Accession #:  1564590-13-1200   ·   File #:  0-19627

Previous ‘10-Q’:  ‘10-Q’ on 8/9/13 for 6/30/13   ·   Next:  ‘10-Q’ on 5/12/14 for 3/31/14   ·   Latest:  ‘10-Q’ on 11/9/23 for 9/30/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/12/13  Biolase, Inc                      10-Q        9/30/13   65:8.2M                                   ActiveDisclosure/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    543K 
 2: EX-4        Ex-4.2                                              HTML     65K 
 3: EX-4        Ex-4.3                                              HTML     63K 
 4: EX-10       Ex-10.4                                             HTML     47K 
 5: EX-31       Ex-31.1                                             HTML     27K 
 6: EX-31       Ex-31.2                                             HTML     28K 
 7: EX-32       Ex-32.1                                             HTML     21K 
 8: EX-32       Ex-32.2                                             HTML     22K 
64: R1          Document and Entity Information                     HTML     41K 
45: R2          Consolidated Balance Sheets                         HTML    136K 
42: R3          Consolidated Balance Sheets (Parenthetical)         HTML     48K 
17: R4          Consolidated Statements Of Operations And           HTML    105K 
                Comprehensive Loss                                               
44: R5          Consolidated Statements Of Cash Flows               HTML    144K 
31: R6          Basis of Presentation                               HTML     55K 
57: R7          Recent Accounting Pronouncements                    HTML     30K 
32: R8          Stock-Based Awards and Per Share Information        HTML    222K 
34: R9          Inventory                                           HTML     37K 
18: R10         Property, Plant, and Equipment                      HTML     53K 
33: R11         Intangible Assets and Goodwill                      HTML    101K 
56: R12         Accrued Liabilities and Deferred Revenue            HTML    110K 
52: R13         Lines Of Credit and Other Borrowings                HTML     55K 
43: R14         Commitments and Contingencies                       HTML     42K 
61: R15         Segment Information                                 HTML     56K 
55: R16         Concentrations                                      HTML     28K 
15: R17         Income Taxes                                        HTML     41K 
20: R18         Subsequent Event                                    HTML     22K 
60: R19         Accounting Policies (Policies)                      HTML    114K 
63: R20         Stock-Based Awards and Per Share Information        HTML    192K 
                (Tables)                                                         
65: R21         Inventory (Tables)                                  HTML     34K 
62: R22         Property, Plant, and Equipment (Tables)             HTML     49K 
47: R23         Intangible Assets and Goodwill (Tables)             HTML     93K 
19: R24         Accrued Liabilities and Deferred Revenue (Tables)   HTML    116K 
30: R25         Segment Information (Tables)                        HTML     47K 
23: R26         Basis of Presentation - Additional Information      HTML     67K 
                (Detail)                                                         
22: R27         Classification of Compensation Expense Associated   HTML     29K 
                with Share-Based Payments (Detail)                               
36: R28         Assumptions Used in Estimating Fair Value of Stock  HTML     32K 
                Options Granted (Detail)                                         
46: R29         Summary of Option Activity (Detail)                 HTML     72K 
53: R30         Cash Proceeds Along with Fair Value Disclosures     HTML     39K 
                Related to grants Exercises and Vesting Options                  
                (Detail)                                                         
27: R31         Stock Based Awards and Per Share Information -      HTML    115K 
                Additional Information (Detail)                                  
37: R32         Components of Inventory (Detail)                    HTML     32K 
59: R33         Inventory - Additional Information (Detail)         HTML     25K 
25: R34         Summary of Property, Plant, and Equipment (Detail)  HTML     36K 
50: R35         Property, Plant, and Equipment - Additional         HTML     22K 
                Information (Detail)                                             
51: R36         Intangible Assets Related to Accumulated            HTML     52K 
                Amortization and Goodwill (Detail)                               
38: R37         Intangible Assets and Goodwill - Additional         HTML     24K 
                Information (Detail)                                             
21: R38         Components of Accrued Liabilities (Detail)          HTML     43K 
49: R39         Changes In Initial Product Warranty Accrual and     HTML     38K 
                Expenses Under Initial and Extended Warranties                   
                (Detail)                                                         
26: R40         Summary of Deferred Revenue (Detail)                HTML     37K 
35: R41         Lines of Credit and Other Borrowings - Additional   HTML    111K 
                Information (Detail)                                             
54: R42         Commitments and Contingencies - Additional          HTML     32K 
                Information (Detail)                                             
29: R43         Summary of Net Revenue by Geographic Location       HTML     24K 
                (Detail)                                                         
48: R44         Segment Information - Additional Information        HTML     30K 
                (Detail)                                                         
41: R45         Concentrations - Additional Information (Detail)    HTML     31K 
24: R46         Income Taxes - Additional Information (Detail)      HTML     57K 
58: R47         Subsequent Event - Additional Information (Detail)  HTML     21K 
40: XML         IDEA XML File -- Filing Summary                      XML     91K 
16: EXCEL       IDEA Workbook of Financial Reports                  XLSX    134K 
39: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS   1.26M 
 9: EX-101.INS  XBRL Instance -- biol-20130930                       XML   1.59M 
11: EX-101.CAL  XBRL Calculations -- biol-20130930_cal               XML    132K 
12: EX-101.DEF  XBRL Definitions -- biol-20130930_def                XML    710K 
13: EX-101.LAB  XBRL Labels -- biol-20130930_lab                     XML    998K 
14: EX-101.PRE  XBRL Presentations -- biol-20130930_pre              XML    800K 
10: EX-101.SCH  XBRL Schema -- biol-20130930                         XSD    161K 
28: ZIP         XBRL Zipped Folder -- 0001564590-13-001200-xbrl      Zip    135K 


‘R2’   —   Consolidated Balance Sheets


This is an IDEA Financial Report.  [ Alternative Formats ]



 
v2.4.0.8
Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Current assets:    
Cash and cash equivalents $ 4,151 $ 2,543
Accounts receivable, less allowance of $554 in 2013 and $304 in 2012 10,802 11,680
Inventory, net 11,745 11,142
Prepaid expenses and other current assets 1,062 1,552
Total current assets 27,760 26,917
Property, plant, and equipment, net 1,711 1,509
Intangible assets, net 200 300
Goodwill 2,926 2,926
Deferred tax asset 16 16
Other assets 246 305
Total assets 32,859 31,973
Current liabilities:    
Lines of credit 5,534 1,637
Accounts payable 9,346 7,663
Accrued liabilities 4,484 6,267
Customer deposits 174 582
Deferred revenue, current portion 3,184 3,226
Total current liabilities 22,722 19,375
Deferred tax liabilities 602 663
Other liabilities, long-term 34 141
Total liabilities 23,358 20,179
Commitments and contingencies (Notes 8, 9, and 13)      
Stockholders’ equity (deficit):    
Preferred stock, par value $0.001, 1,000 shares authorized, no shares issued and outstanding      
Common stock, par value $0.001, 50,000 shares authorized; 36,815 and 33,248 shares issued in 2013 and 2012, respectively; and 34,852 and 31,284 shares outstanding in 2013 and 2012, respectively 37 34
Additional paid-in capital 147,676 140,747
Accumulated other comprehensive loss (297) (320)
Accumulated deficit (121,516) (112,268)
Stockholders' equity excluding treasury stock 25,900 28,193
Treasury stock (cost of 1,964 shares repurchased) (16,399) (16,399)
Total stockholders’ equity 9,501 11,794
Total liabilities and stockholders’ equity $ 32,859 $ 31,973

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:11/12/138-K
For Period end:9/30/13
12/31/1210-K
9/15/09
 List all Filings 
Top
Filing Submission 0001564590-13-001200   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 30, 8:14:56.1pm ET